Search results for "Highlights"


 
Results 201 - 210 of about 379 for "Highlights".
Sort by: Relevance | Newest | Oldest

Liraglutide may offer high-risk patients protection from CV events, death, study finds

The Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial, which was funded by Novo Nordisk and the National Institutes of Health, randomized 9,340 patients ages 50 years and older to 1.8 mg of liraglutide per day via injection or placebo in addition to standard care.
https://diabetes.acponline.org/archives/2016/07/15/1.htm
15 Jul 2016

Spotlight on cognitive effects of diabetes

Two recent studies looked at the effects of diabetes on the brain, one focusing on mild cognitive impairment and the other on brain imaging findings.
https://diabetes.acponline.org/archives/2017/05/12/5.htm
12 May 2017

Screening tool identifies high-risk drivers with type 1 diabetes and website helps to avoid future accidents

Significant independent predictors of risk for driving mishaps included annual driving distance and presence of peripheral neuropathy. Researchers developed an 11-item questionnaire to further refine risk prediction.
https://diabetes.acponline.org/archives/2017/05/12/3.htm
12 May 2017

Mortality rates, deaths from vascular causes among U.S. adults with diabetes have decreased over time

Between 1988 to 1994 and 2010 to 2015, all-cause mortality rates among adults with diabetes dropped most in men and those ages 65 to 74 years, and there was no decline in death rates among those ages 20 to 44 years.
https://diabetes.acponline.org/archives/2018/06/08/1.htm
8 Jun 2018

Approved drugs for diabetic neuropathy better than placebo, review finds

In addition to approved drugs duloxetine, pregabalin, and tapentadol, some benefits were found with venlafaxine, oxcarbazepine, tricyclic antidepressants, tramadol, and botulinum toxin.
https://diabetes.acponline.org/archives/2017/04/14/2.htm
14 Apr 2017

Spotlight on diabetes incidence and complications

Mortality and cardiovascular complications from diabetes have gone down, but incidence rates among youth are up, according to recent studies of Swedish and American patients, respectively.
https://diabetes.acponline.org/archives/2017/04/14/5.htm
14 Apr 2017

VA's patient-centered model may not aid glycemic or lipid control

A retrospective cohort analysis assessed the impact of a change in primary care model on diabetes outcomes among patients receiving care at seven Midwestern Veterans Affairs facilities.
https://diabetes.acponline.org/archives/2018/04/13/1.htm
13 Apr 2018

Higher prevalence of complications in young adults diagnosed with type 2 vs. type 1 diabetes

Compared to those with type 1 diabetes, participants with type 2 had a significantly higher age-adjusted prevalence of diabetic kidney disease, retinopathy, peripheral, arterial stiffness, and hypertension by age 21.
https://diabetes.acponline.org/archives/2017/03/10/3.htm
10 Mar 2017

Dapagliflozin associated with lower risk for all-cause mortality in type 2 diabetes regardless of CVD risk, study finds

The population-based retrospective cohort study included 22,124 type 2 diabetes patients from a British national primary care database, 4,444 of whom had taken dapagliflozin.
https://diabetes.acponline.org/archives/2017/03/10/2.htm
10 Mar 2017

Sickle cell trait affects HbA1c's accuracy as a measure of glycemia, study finds

Mean HbA1c was 5.7% in the African-American participants with sickle cell trait and 6.0% in those without, despite similar mean fasting and two-hour glucose values.
https://diabetes.acponline.org/archives/2017/02/10/2.htm
10 Feb 2017

Result Page: Prev   16   17   18   19   20   21   22   23   24   25   Next